MedRhythms and Edwards Health Care Team Up for National Distribution of Rehabilitation Devices

MedRhythms Partners with Edwards Health Care Services for Distribution

MedRhythms, Inc., celebrated for its pioneering approach in neurologic and physical rehabilitation, has announced a strategic alliance with Edwards Health Care Services (EHCS), a member of the GEMCORE Family. This partnership, revealed on September 16, 2025, aims to enhance the distribution of MedRhythms' innovative rehabilitation devices, specifically InTandem® and MOVIVE™. These devices are designed to support adults recovering from chronic stroke and individuals with Parkinson's disease (PD), respectively.

A New Era of Accessibility

The collaboration is set to make these products available to patients with Medicare and commercial insurance nationwide. Joel Behnke, Chief Commercial Officer at MedRhythms, expressed that this partnership significantly broadens access to vital rehabilitation products. He stated, "Building on our existing national coverage for Veterans, we can now offer life-changing therapy to many more individuals from the comfort of their homes."

The enhanced distribution model aligns with MedRhythms' recently established framework for national reimbursement, following critical decisions by the Center for Medicare and Medicaid Services (CMS). Importantly, a new Healthcare Common Procedure Coding System (HCPCS) code (E3200) has been implemented, facilitating reimbursement for gait modulation systems employing rhythmic auditory stimulation (RAS), a cornerstone of MedRhythms' therapeutic approach.

Innovative Therapies Change Lives

Edwards Health Care Services shares a similar commitment to improving access to groundbreaking therapies that empower individuals to lead healthier and more independent lives. Matthew Edwards, CEO of EHCS, highlighted, "This partnership allows us to deliver proven neurorehabilitation solutions directly to patients, promoting better mobility and enhanced quality of life for those overcoming stroke recovery and managing Parkinson's disease."

Larry Jasinski, CEO of MedRhythms, emphasized the partnership's strategic significance, describing it as a vital step in their growth and commitment to patients with neurologic diseases. He remarked, "With increased access through our collaboration with EHCS and the support of commercial insurance and Medicare, we can make a substantial clinical impact while simultaneously establishing a robust business model in a rapidly expanding market."

Effective Therapeutic Solutions

Both InTandem and MOVIVE leverage the power of music to deliver RAS, which has proven effective in neurorehabilitation over more than three decades of research. MedRhythms' innovative platform enables the scalable application of RAS outside conventional healthcare environments, yielding positive clinical outcomes and long-term benefits in stroke and Parkinson's disease rehabilitation.

According to a multi-site randomized controlled trial published in Nature Communications, participants using InTandem exhibited statistically significant improvements in walking speed and showed over three times higher responsiveness compared to those in an active control group. MOVIVE's feasibility study indicated similar gains, as it successfully enhanced gait quality and facilitated moderate-intensity gait training for participants with PD.

Get Involved

Both InTandem and MOVIVE are prescription-based home-use devices, ensuring that users can embark on their rehabilitation journey with guided support. If you're interested in prescribing InTandem for chronic stroke patients, visit intandemrx.com. For those looking to recommend MOVIVE for Parkinson's patients, further details can be found at movive.com.

About MedRhythms

MedRhythms is on the frontier of developing advanced neurotherapeutic solutions that improve walking, mobility, and other related functional outcomes. The company works through a proprietary technology platform that integrates sensors, software, and music with advanced neuroscience principles to target neural pathways effectively. Headquartered in Portland, Maine, MedRhythms is dedicated to creating a robust pipeline of products tailored for various neurological conditions, including strokes, multiple sclerosis, and Parkinson's disease.

For more information, please visit www.medrhythms.com.